Janus Henderson Investors US’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Janus Henderson Investors US’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$26.9M	Sell	900,967 -239,172	-21%	-$6.11M	0.02%	555
2016 Q4	$20M	Sell	1,140,139 -77,578	-6%	-$1.49M	0.02%	613
2016 Q3	$29M	Sell	1,217,717 -26,025	-2%	-$490K	0.02%	530
2016 Q2	$19.9M	Buy	1,243,742 +118,838	+11%	+$2.13M	0.02%	575
2016 Q1	$23.5M	Buy	1,124,904 +196,588	+21%	+$3.51M	0.02%	556
2015 Q4	$25.1M	Buy	928,316 +72,744	+9%	+$1.98M	0.02%	568
2015 Q3	$23.8M	Buy	+855,572	New	+$27M	0.02%	570

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Investors US's LJPC Position: Q1 2017 in Review

Janus Henderson Investors US reduced its La Jolla Pharmaceutical Company (LJPC) stake by 21% in Q1 2017, selling an estimated $6.11M and leaving 900,967 shares worth $26.9M. The position accounts for 0.02% of the portfolio, ranked #555.

Janus Henderson Investors US first reported a position in LJPC in Q3 2015 and has held it in 7 quarters since. The position peaked at $29M in Q3 2016. 96 funds tracked by Wall St. Rank hold LJPC as of Q1 2017.

Janus Henderson Investors US held 900,967 shares of La Jolla Pharmaceutical Company worth $26.9M as of Q1 2017.
Janus Henderson Investors US sold 239,172 La Jolla Pharmaceutical Company shares in Q1 2017, an estimated $6.11M.
La Jolla Pharmaceutical Company made up 0.02% of Janus Henderson Investors US's portfolio in Q1 2017, its #555 holding.
Janus Henderson Investors US first reported a position in La Jolla Pharmaceutical Company in Q3 2015 and has held it in 7 quarters since.
Janus Henderson Investors US's La Jolla Pharmaceutical Company position peaked at $29M in Q3 2016.
96 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.